Results 1 to 10 of about 3,196 (170)

Epilepsy in Juvenile Neuronal Ceroid Lipofuscinosis

open access: yesPediatric Neurology Briefs, 2000
The clinical characteristics of epilepsy and optimal antiepileptic drug therapy were surveyed in 60 patients (mean age 16 years, range 5-33) with juvenile neuronal ceroid lipofuscinosis (JNCL), followed at the University of Helsinki, Finland.
J Gordon Millichap
doaj   +2 more sources

Lamotrigine Therapy in Neuronal Lipofuscinosis

open access: yesPediatric Neurology Briefs, 1999
Lamotrigine (LTG) long-term anticonvulsant therapy was evaluated in 29 patients, aged 6-28 years (mean, 14 years), with juvenile neuronal ceroid lipofuscinosis (JNCL), followed for 1-6 years (mean, 3 years) at the Hospital for Children and Adolescents ...
J Gordon Millichap
doaj   +2 more sources

Subdural Effusion and Infantile Neuronal Ceroid Lipofuscinosis

open access: yesPediatric Neurology Briefs, 2010
During the course of an ongoing NIH clinical study evaluating the benefit of cysteamine and N-acetylcysteine in 9 patients with infantile neuronal ceroid lipofuscinosis (INCL), 4 were found to have subdural fluid collections without mass effect.
J Gordon Millichap
doaj   +2 more sources

Spino-Cerebellar Degeneration and Ceroid Lipofuscinosis

open access: yesPediatric Neurology Briefs, 1988
Neuronal ceroid lipofuscinosis (NCL) presenting in two different forms within a family is reported from the New York State Office of Mental Retardation and Developmental Disabilities, Institute for Basic Research, 10560 Forest Hill Rd, Staten Island, NY ...
J Gordon Millichap
doaj   +2 more sources

MRI findings of neuronal ceroid lipofuscinosis in a cat [PDF]

open access: yesJournal of Feline Medicine and Surgery Open Reports, 2018
Case summary A 2-year-old male domestic shorthair cat presented to the University of Liverpool Small Animal Teaching Hospital with a 2 week history of altered mentation, blindness and focal epileptic seizures.
Crystal White   +5 more
doaj   +2 more sources

Imaging data on characterization of retinal autofluorescent lesions in a mouse model of juvenile neuronal ceroid lipofuscinosis (CLN3 disease) [PDF]

open access: yesData in Brief, 2020
Juvenile neuronal ceroid lipofuscinosis (JNCL, aka. juvenile Batten disease or CLN3 disease), a lethal pediatric neurodegenerative disease without cure, often presents with vision impairment and characteristic ophthalmoscopic features including focal ...
Qing Jun Wang   +3 more
doaj   +2 more sources

Reduction of microglial progranulin does not exacerbate pathology or behavioral deficits in neuronal progranulin-insufficient mice

open access: yesNeurobiology of Disease, 2019
Loss-of-function mutations in progranulin (GRN), most of which cause progranulin haploinsufficiency, are a major autosomal dominant cause of frontotemporal dementia (FTD).
Andrew E. Arrant   +8 more
doaj   +1 more source

MRI findings in neuronal ceroid lipofuscinosis

open access: yesRadiology Case Reports, 2020
Neuronal ceroid lipofuscinosis is a rare cause for developmental delay and seizures that results in neurodegeneration. Presented here is a case of a 5-year-old male who presented for MRI following a delay in achieving developmental milestones and ...
Anna M. Crain   +3 more
doaj   +1 more source

Lipofuscinosis ceroidea neuronal 6 (enfermedad Kufs tipo A): Reporte de caso en Colombia

open access: yesActa Neurológica Colombiana, 2021
INTRODUCCIÓN: Las lipofuscinosis ceroideas neuronales (CLN) son un grupo de enfermedades neurodegenerativas de inicio generalmente en la infancia, caracterizadas por acumulación intracelular de material de almacenamiento autofluorescente.
Diana Vanessa González Pabón   +2 more
doaj   +1 more source

Phenotypic characterization of a mouse model of juvenile neuronal ceroid lipofuscinosis

open access: yesNeurobiology of Disease, 2008
Juvenile neuronal ceroid lipofuscinosis (JNCL) is an autosomal recessively inherited neurodegenerative disorder that results from mutations in the CLN3 gene.
Martin L. Katz   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy